what we do link

Biovation (NYX: MRK) - Antibody and protein engineering

Biovation (NYX: MRK)

Biotechnology company Biovation achieved a multi-million exit when it was sold to Merck in 2000.

Related People

Brian Kerr, Brian Kerr, Partner: Healthcare: Healthcare

Back link

Companies & Sectors

Information Technology Link

Information Technology

Healthcare Link

Energy Technology Link

Energy Technology

©2010 Scottish Equity Partners LLP // Authorised and Regulated by the Financial Services Authority
Sitemap | Privacy Policy | Home